Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer

Recruiting N/A Interventional Study
Lung Cancer Quality of Life
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
220 (estimated)
Sponsor
University of Bayreuth · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of the study is to determine whether a preference-oriented quality of life monitoring with defined diagnostic and therapeutic options improves quality of life in patients with lung cancer during routine follow-up care.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. primary diagnosis of lung cancer (ICD C33/C34, all stages) 2. treatment in one of six recruiting hospitals treating patients with lung cancer (University Hospital Regensburg, Hospital Barmherzige Brüder Regensburg, Hospital Bayreuth, Hospital Coburg, Hospital Kulmbach, Hospit…
Contacts

Martin Emmert, PhD, Prof.

+49 160 92203562

martin.emmert@uni-bayreuth.de

CONTACT

Monika Klinkhammer-Schalke, MD, Prof.

+49-941-943-1803

monika.klinkhammer-schalke@ur.de

CONTACT